Recipharm appoints Tobias Hägglöv as new CFO
10 May 2018 -

Recipharm AB (STO:RECIB), a Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry, announced on Wednesday that it has appointed Tobias Hägglöv as new CFO of the company, effective later in the year. Hägglöv will also be a member of Recipharm's group management team.

Most recently, Hägglöv was CFO at LEAX. Prior to that, Hägglöv has comprehensive experience from finance positions at Electrolux, SAS and Accenture.

Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, as well as pharmaceutical product development.